Pretraga

Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1257921

Use of screening tools to assess comorbidities and adverse events in patients with epilepsy. A European Reference Network for Rare and Complex Epilepsies (EpiCARE) survey

(European Reference Network EpiCARE) Henning, Oliver; Alfstad, Kristin Å; Johannessen Landmark, Cecilie; Helmstaedter, Christoph; Lossius, MI; Holth Skogan, Annette;
Use of screening tools to assess comorbidities and adverse events in patients with epilepsy. A European Reference Network for Rare and Complex Epilepsies (EpiCARE) survey // Seizure, 101 (2022), 237-243 doi:10.1016/j.seizure.2022.09.008 (međunarodna recenzija, članak, znanstveni)

CROSBI ID: 1257921 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Use of screening tools to assess comorbidities and adverse events in patients with epilepsy. A European Reference Network for Rare and Complex Epilepsies (EpiCARE) survey

Autori
Henning, Oliver ; Alfstad, Kristin Å ; Johannessen Landmark, Cecilie ; Helmstaedter, Christoph ; Lossius, MI ; Holth Skogan, Annette ;

Kolaboracija
European Reference Network EpiCARE

Izvornik
Seizure (1059-1311) 101 (2022); 237-243

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
epilepsy ; screening tools ; comorbidities ; adverse events

Sažetak
Purpose: As comorbidities can affect treatment decisions, quality of life, and prognosis in epilepsy, it is important that they are detected and addressed as soon as possible. Screening tools can help by rapidly assessing various additional challenges in epilepsy. Methods: To map the use and perceived benefit of different screening instruments for quality of life, psychiatric comorbidity, and cognition, along with side effects from anti-seizure medication in Europe, we sent an online questionnaire to dedicated epilepsy centres departments within the European Reference Network for Rare and Complex Epilepsies (EpiCARE). Results: Among the 40 hospitals in the EpiCARE network, we received responses from 25 (63%), with 28 indi- vidual respondents. Most respondents reported using screening for quality of life (86%) and psychiatric co- morbidity (82%), but relatively few (14%) screen for sexual problems. Many (47) different tools were used for evaluation of cognitive dysfunction, but just a few (5) different tools were used to screen for adverse events. The optimization of individual patient care was one main reason given for using screening tools (58%-100% - depending on purpose of tool), another was research (50% - 88% - depending on purpose of tool). A major benefit of using screening tools perceived by the respondents is the detection of “hidden” comorbidity (67% - 90% - depending on purpose of tool). Conclusion: In the absence of a broad consensus regarding use of screening tools, practices vary considerably among epilepsy centres. Greater emphasis should be directed towards harmonizing use of screening tools. Future research should address how screening results influence treatment choices, and how these might affect clinical care.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA

Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb

Profili:

Avatar Url Željka Petelin Gadže (autor)

Poveznice na cjeloviti tekst rada:

doi doi.org

Citiraj ovu publikaciju:

(European Reference Network EpiCARE) Henning, Oliver; Alfstad, Kristin Å; Johannessen Landmark, Cecilie; Helmstaedter, Christoph; Lossius, MI; Holth Skogan, Annette;
Use of screening tools to assess comorbidities and adverse events in patients with epilepsy. A European Reference Network for Rare and Complex Epilepsies (EpiCARE) survey // Seizure, 101 (2022), 237-243 doi:10.1016/j.seizure.2022.09.008 (međunarodna recenzija, članak, znanstveni)
(European Reference Network EpiCARE) (European Reference Network EpiCARE) Henning, O., Alfstad, K., Johannessen Landmark, C., Helmstaedter, C., Lossius, M., Holth Skogan, A. & (2022) Use of screening tools to assess comorbidities and adverse events in patients with epilepsy. A European Reference Network for Rare and Complex Epilepsies (EpiCARE) survey. Seizure, 101, 237-243 doi:10.1016/j.seizure.2022.09.008.
@article{article, author = {Henning, Oliver and Alfstad, Kristin \AA and Johannessen Landmark, Cecilie and Helmstaedter, Christoph and Lossius, MI and Holth Skogan, Annette}, year = {2022}, pages = {237-243}, DOI = {10.1016/j.seizure.2022.09.008}, keywords = {epilepsy, screening tools, comorbidities, adverse events}, journal = {Seizure}, doi = {10.1016/j.seizure.2022.09.008}, volume = {101}, issn = {1059-1311}, title = {Use of screening tools to assess comorbidities and adverse events in patients with epilepsy. A European Reference Network for Rare and Complex Epilepsies (EpiCARE) survey}, keyword = {epilepsy, screening tools, comorbidities, adverse events} }
@article{article, author = {Henning, Oliver and Alfstad, Kristin \AA and Johannessen Landmark, Cecilie and Helmstaedter, Christoph and Lossius, MI and Holth Skogan, Annette}, year = {2022}, pages = {237-243}, DOI = {10.1016/j.seizure.2022.09.008}, keywords = {epilepsy, screening tools, comorbidities, adverse events}, journal = {Seizure}, doi = {10.1016/j.seizure.2022.09.008}, volume = {101}, issn = {1059-1311}, title = {Use of screening tools to assess comorbidities and adverse events in patients with epilepsy. A European Reference Network for Rare and Complex Epilepsies (EpiCARE) survey}, keyword = {epilepsy, screening tools, comorbidities, adverse events} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE

Citati:

    Altmetrijski pokazatelji:


    Podijeli:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font
    CROSBI koristi kolačiće (cookies) kako bi poboljšao funkcionalnost stranice.